13th edition

Format
HYBRID

December 3rd & 4th, 2024

IN-PERSON | LILLE, FR

December 11th& 12th 2024

ONLINE MEETINGS

Stand F20-F21

2024 Edition

Apoliktos

France

Apoliktos is a preinception-stage biotech in immuno-oncology with an international team of experts and founders aiming to develop personalized therapeutics against multiple myeloma.
Apoliktos is establishing a platform, which uses a modular library of neoantigen binders and antibody backbones connected at the patient’s bedside for targeted personalized therapeutic antibodies.

Scroll to Top
  • No products in the cart.